Research ExplorerPublicationsIntracranial hemorrhage, outcome, and mortality after intra-...

Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulants.

Standard

Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulants. / Marchis, De; Marco, Gian; Jung, Simon; Colucci, Giuseppe; Meier, Niklaus; Fischer, Urs; Weck, Anja; Mono, Marie-Luise; Galimanis, Aekaterini; Mattle, Heinrich P; Schroth, Gerhard; Gralla, Jan; Brekenfeld, Caspar; Brekenfeld, Caspar.

In: STROKE, Vol. 42, No. 11, 11, 2011, p. 3061-3066.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Marchis, D, Marco, G, Jung, S, Colucci, G, Meier, N, Fischer, U, Weck, A, Mono, M-L, Galimanis, A, Mattle, HP, Schroth, G, Gralla, J, Brekenfeld, C & Brekenfeld, C 2011, 'Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulants.', STROKE, vol. 42, no. 11, 11, pp. 3061-3066. <http://www.ncbi.nlm.nih.gov/pubmed/21980194?dopt=Citation>

APA

Marchis, D., Marco, G., Jung, S., Colucci, G., Meier, N., Fischer, U., Weck, A., Mono, M-L., Galimanis, A., Mattle, H. P., Schroth, G., Gralla, J., Brekenfeld, C., & Brekenfeld, C. (2011). Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulants. STROKE, 42(11), 3061-3066. [11]. http://www.ncbi.nlm.nih.gov/pubmed/21980194?dopt=Citation

Vancouver

Marchis D, Marco G, Jung S, Colucci G, Meier N, Fischer U et al. Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulants. STROKE. 2011;42(11):3061-3066. 11.

Bibtex

@article{646c699297bb4b54a69c31bc0915ba13,
title = "Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulants.",
abstract = "Use of intravenous tissue-type plasminogen activator (IV tPA) for acute ischemic stroke is restricted to patients with an international normalized ratio (INR) less than 1.7. However, a recent study showed increased risk of symptomatic intracranial hemorrhage after IV tPA use in patients with oral anticoagulants (OAC) even with an INR less than 1.7. The present study assessed the risk of symptomatic intracranial hemorrhage, clinical outcome, and mortality after intra-arterial therapy (IAT) in patients with and without previous use of OAC.",
author = "De Marchis and Gian Marco and Simon Jung and Giuseppe Colucci and Niklaus Meier and Urs Fischer and Anja Weck and Marie-Luise Mono and Aekaterini Galimanis and Mattle, {Heinrich P} and Gerhard Schroth and Jan Gralla and Caspar Brekenfeld and Caspar Brekenfeld",
year = "2011",
language = "English",
volume = "42",
pages = "3061--3066",
journal = "STROKE",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

RIS

TY - JOUR

T1 - Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulants.

AU - Marchis, De

AU - Marco, Gian

AU - Jung, Simon

AU - Colucci, Giuseppe

AU - Meier, Niklaus

AU - Fischer, Urs

AU - Weck, Anja

AU - Mono, Marie-Luise

AU - Galimanis, Aekaterini

AU - Mattle, Heinrich P

AU - Schroth, Gerhard

AU - Gralla, Jan

AU - Brekenfeld, Caspar

AU - Brekenfeld, Caspar

PY - 2011

Y1 - 2011

N2 - Use of intravenous tissue-type plasminogen activator (IV tPA) for acute ischemic stroke is restricted to patients with an international normalized ratio (INR) less than 1.7. However, a recent study showed increased risk of symptomatic intracranial hemorrhage after IV tPA use in patients with oral anticoagulants (OAC) even with an INR less than 1.7. The present study assessed the risk of symptomatic intracranial hemorrhage, clinical outcome, and mortality after intra-arterial therapy (IAT) in patients with and without previous use of OAC.

AB - Use of intravenous tissue-type plasminogen activator (IV tPA) for acute ischemic stroke is restricted to patients with an international normalized ratio (INR) less than 1.7. However, a recent study showed increased risk of symptomatic intracranial hemorrhage after IV tPA use in patients with oral anticoagulants (OAC) even with an INR less than 1.7. The present study assessed the risk of symptomatic intracranial hemorrhage, clinical outcome, and mortality after intra-arterial therapy (IAT) in patients with and without previous use of OAC.

M3 - SCORING: Journal article

VL - 42

SP - 3061

EP - 3066

JO - STROKE

JF - STROKE

SN - 0039-2499

IS - 11

M1 - 11

ER -